BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32145089)

  • 21. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
    Kim HJ; Yoon KA; Yoon HJ; Hong JM; Lee MJ; Lee IK; Kim SY
    J Leukoc Biol; 2013 Jul; 94(1):99-107. PubMed ID: 23657115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.
    Nakajima S; Watashi K; Ohashi H; Kamisuki S; Izaguirre-Carbonell J; Kwon AT; Suzuki H; Kataoka M; Tsukuda S; Okada M; Moi ML; Takeuchi T; Arita M; Suzuki R; Aizaki H; Kato T; Suzuki T; Hasegawa H; Takasaki T; Sugawara F; Wakita T
    J Virol; 2016 Oct; 90(20):9058-74. PubMed ID: 27489280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays.
    Wu M; Li J; Yue L; Bai L; Li Y; Chen J; Zhang X; Yuan Z
    Antiviral Res; 2018 Apr; 152():45-52. PubMed ID: 29432776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of Host ATR-CHK1 Pathway in Hepatitis B Virus Covalently Closed Circular DNA Formation.
    Luo J; Luckenbaugh L; Hu H; Yan Z; Gao L; Hu J
    mBio; 2020 Feb; 11(1):. PubMed ID: 32071277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.
    Sato K; Kamada T
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Feb; 158(2):201-6. PubMed ID: 21056113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis.
    Xia Y; Stadler D; Lucifora J; Reisinger F; Webb D; Hösel M; Michler T; Wisskirchen K; Cheng X; Zhang K; Chou WM; Wettengel JM; Malo A; Bohne F; Hoffmann D; Eyer F; Thimme R; Falk CS; Thasler WE; Heikenwalder M; Protzer U
    Gastroenterology; 2016 Jan; 150(1):194-205. PubMed ID: 26416327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
    Front Immunol; 2021; 12():745802. PubMed ID: 34671360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking neddylation elicits antiviral effect against hepatitis B virus replication.
    Abounouh K; Kayesh MEH; Altawalah H; Kitab B; Murakami S; Ogawa S; Tanaka Y; Dehbi H; Pineau P; Kohara M; Benjelloun S; Tsukiyama-Kohara K; Ezzikouri S
    Mol Biol Rep; 2022 Jan; 49(1):403-412. PubMed ID: 34716866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
    Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K
    Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a first-in-class orally available HBV cccDNA inhibitor.
    Wang L; Zhu Q; Zhang JD; Zhang Y; Ni X; Xiang K; Jiang J; Li B; Yu Y; Hu H; Zhang M; Wu W; Zeng J; Yan Z; Dai J; Sun K; Zhang X; Chen D; Feng S; Sach-Peltason L; Young JAT; Gao L
    J Hepatol; 2023 Apr; 78(4):742-753. PubMed ID: 36587899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.
    Spillmann F; Van Linthout S; Miteva K; Lorenz M; Stangl V; Schultheiss HP; Tschöpe C
    Atherosclerosis; 2014 Jan; 232(1):1-9. PubMed ID: 24401210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity.
    Tang L; Remiszewski S; Snedeker A; Chiang LW; Shenk T
    Antiviral Res; 2024 Jun; 226():105888. PubMed ID: 38641024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
    Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
    J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fowl Adenovirus Serotype 4 Induces Hepatic Steatosis via Activation of Liver X Receptor-α.
    Yuan F; Hou L; Wei L; Quan R; Wang J; Liu H; Liu J
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus sensitivity to interferon-α in hepatocytes is more associated with cellular interferon response than with viral genotype.
    Shen F; Li Y; Wang Y; Sozzi V; Revill PA; Liu J; Gao L; Yang G; Lu M; Sutter K; Dittmer U; Chen J; Yuan Z
    Hepatology; 2018 Apr; 67(4):1237-1252. PubMed ID: 29059468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
    Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
    Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LXR agonists promote the proliferation of neural progenitor cells through MEK-ERK pathway.
    Wang JZ; Fang Y; Ji WD; Xu H
    Biochem Biophys Res Commun; 2017 Jan; 483(1):216-222. PubMed ID: 28034754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Lee TY; Chang PL; Chen WT; Juang HH
    Prostate; 2015 May; 75(6):603-15. PubMed ID: 25560459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Analysis of the Antiviral Effects Mediated by Type I and III Interferons in Hepatitis B Virus-Infected Hepatocytes.
    Bockmann JH; Stadler D; Xia Y; Ko C; Wettengel JM; Schulze Zur Wiesch J; Dandri M; Protzer U
    J Infect Dis; 2019 Jul; 220(4):567-577. PubMed ID: 30923817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.